Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Multivalent Kaposi sarcoma-associated herpesvirus-like particles and uses thereof

Multivalent Kaposi sarcoma-associated herpesvirus-like particles and uses thereof

US Patent 12156911 · Granted Dec 3, 2024

Estimated economic value: $11,019,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Multivalent Epstein-Barr virus-like particles and uses thereof2025
Multivalent Epstein-Barr virus-like particles and uses thereof2025
Multivalent Epstein-Barr virus-like particles and uses thereof2025
MVA vaccine for delivery of a UL128 complex and preventing CMV infection2024
Genetically modified recombinant vaccinia ankara (RMVA) vaccines of improved sta2024
Epstein-Barr virus antibodies and uses thereof2024
Epstein-Barr virus antibodies and uses thereof2024
Multivalent Epstein-Barr virus-like particles and uses thereof2024
Multivalent Epstein-Barr virus-like particles and uses thereof2024
Multivalent Epstein-Barr virus-like particles and uses thereof2024
Expression system for expressing herpesvirus glycoprotein complexes2023
MVA vaccine for delivery of a UL128 complex and preventing CMV infection2023